0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Sclerochoroidal Calcification Is Primarily a Scleral Condition Based on Enhanced Depth Imaging Optical Coherence Tomography FREE

Adrian T. Fung, MBBS, MMed1; Juan D. Arias, MD1; Carol L. Shields, MD1; Jerry A. Shields, MD1
[+] Author Affiliations
1Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania
JAMA Ophthalmol. 2013;131(7):960-963. doi:10.1001/jamaophthalmol.2013.67.
Text Size: A A A
Published online

Sclerochoroidal calcification (SC) is found in elderly white individuals with calcium pyrophosphate deposition in the sclera and/or choroid, appearing as a typical yellow subretinal mass usually along the retinal vascular arcades.14 Most cases are idiopathic, but some have a systemic relationship.1,2 We review multimodal imaging findings of SC.

Clinical and imaging data of 17 SC lesions in 13 eyes of 9 patients diagnosed at the Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania, were analyzed retrospectively. Institutional review board approval was obtained, and all patients provided written informed consent.

All patients underwent ocular examination, fundus photography, B-scan ultrasonography, fundus autofluorescence imaging using the Topcon TRC-50DX Retinal Camera (Topcon America; excitation light bandwidth, 580 nm; barrier filter bandwidth, 695 nm), infrared reflectance imaging, and enhanced depth imaging optical coherence tomography (EDI-OCT) using the Heidelberg Spectralis HRA + OCT (Heidelberg Engineering Inc). Analysis of the imaging was performed by 2 independent observers (A.T.F. and J.D.A.), with consensus used to resolve disagreements.

There were 17 SC lesions in 13 eyes of 9 patients (5 male), 5 of whom had unilateral SC. All patients were white, and the mean age was 74 years (median, 73 years; range, 60-88 years). The referring diagnoses were SC (n = 3), choroidal tumor (n = 3), choroidal nevus (n = 1), choroidal melanoma (n = 1), and choroidal metastasis (n = 1). The mean best-corrected visual acuity was 20/33 (median, 20/25; range, 20/20-20/150).

All lesions were postequatorial and most were superotemporal (n = 12). The shapes of the lesions were geographic (n = 9), circular (n = 4), ill-defined (n = 3), and annular (n = 1). All lesions were orange to yellow. The mean greatest basal diameter was 3.5 mm (range, 1.0-7.0 mm), and the mean thickness on B-scan ultrasonography was 1.6 mm (range, 1.0-3.5 mm). All lesions were acoustically solid with shadowing suggestive of calcification. Orbital computed tomography performed on 1 patient demonstrated bilateral radiodense scleral lesions, confirming calcification.

On fundus autofluorescence imaging, 16 lesions were homogeneously hyperautofluorescent and 1 was homogeneously hypoautofluorescent with a hyperautofluorescent halo. Thirteen of 17 SC lesions had adequate infrared reflectance imaging and EDI-OCT. Of these, the lesions were hyperreflective (n = 11) or hyporeflective (n = 2) on infrared reflectance imaging. On EDI-OCT, all lesions originated within the sclera with thinning or absence of the overlying choroid (mean thickness, 28 μm; range, 0-119 μm) (Table 1 and Table 2). The lesions were elevated with undulating contour (n = 11) or flat (n = 2). The anterior scleral surface was irregular and “rocky” (n = 5) (Figure) or smooth and “rolling” (n = 8). The lesions were moderately reflective (n = 10) with bright anterior band (n = 3). The posterior margin of the lesion, and therefore the thickness, could not be identified in any case. By EDI-OCT, the mean diameter was 3689 μm (range, 2345-5804 μm). Overlying features included outer nuclear layer thinning (n = 2), external limiting membrane disruption (n = 1), inner segment–outer segment junction absence (n = 2), subretinal fluid (n = 1), retinal pigment epithelium alteration (n = 4), and pigment epithelial detachment (n = 1).

Table Graphic Jump LocationTable 1.  Lesion Findings of Sclerochoroidal Calcification on Enhanced Depth Imaging Optical Coherence Tomography in 9 Patients With 13 Lesions
Table Graphic Jump LocationTable 2.  Choroidal and Retinal Findings of Sclerochoroidal Calcification on Enhanced Depth Imaging Optical Coherence Tomography in 9 Patients With 13 Lesions
Place holder to copy figure label and caption
Figure.
Findings in an 86-Year-Old Woman With Sclerochoroidal Calcification

A, Geographic yellow subretinal lesion underlies the superotemporal retinal vascular arcade. B, B-scan ultrasonography demonstrates an acoustically solid mass with shadowing and thickness of 1.7 mm. C, The lesion is hyperautofluorescent. D, Infrared reflectance imaging shows bright clumps. E, Enhanced depth imaging optical coherence tomography demonstrates an elevated scleral mass with a “rocky” surface (arrows). There is thinning of the overlying choroid and outer nuclear layer as well as absence of the external limiting membrane and inner segment–outer segment junction. Slight irregular thickening of the retinal pigment epithelium is present.

Graphic Jump Location

The clinical and ultrasonographic findings of SC lesions are consistent with previous reports.13 Nearly all lesions were homogeneously hyperautofluorescent. Fundus hyperautofluorescence is typically related to increased lipofuscin in diseased retinal pigment epithelium. However, in most of our cases, the retinal pigment epithelium appeared normal clinically, with normal thickness on EDI-OCT. Therefore, we propose that thinning or absence of the overlying choroid, documented on EDI-OCT, could have allowed for unmasking of underlying scleral hyperautofluorescence. Eleven of the 13 SC lesions were hyperreflective on infrared reflectance imaging, consistent with reflectance from scleral collagen. Alternatively, intrinsic hyperautofluorescence of calcific tissue within SC may explain our fundus autofluorescence imaging findings.

The most remarkable finding on EDI-OCT was that all SC lesions originated from within the sclera, with thinning or absence of the overlying choroid. In addition, the irregular surface contour is unlike choroidal nevus or small melanoma, which display a gentle, uniform anterior slope. The rocky configuration may be unique to SC and, to our knowledge, has not previously been reported with other choroidal conditions on EDI-OCT. The inability to identify the posterior margin of each lesion may relate to the reflectivity of the calcific material, thickness, or both.

To our knowledge, there are only 2 reports of EDI-OCT of SC, and both had this rocky configuration.5,6 A clinicopathologic correlation of SC in 3 globes from 2 patients found 2 types of scleral calcification, including tophuslike conglomeration of calcium pyrophosphate crystals and diffuse noncrystalline calcification.7 The uvea was uninvolved except in one section where 2 large crystalline deposits were visualized projecting into the outer choroid. These pathologic observations correlate with our observations on the scleral localization of this condition on EDI-OCT.

The use of multimodal imaging can assist in establishing the diagnosis of SC. Six of the 9 patients (67%) were referred with a diagnosis other than SC. The differential diagnosis of SC includes choroidal osteoma, metastasis, amelanotic nevus or melanoma, lymphoma, and granuloma.13 One main dissimilarity is that these lesions arise primarily from the choroid, whereas SC appears to be primarily a scleral rather than sclerochoroidal condition.

Corresponding Author: Dr C. L. Shields, Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Ste 1440, Philadelphia, PA 19107 (carol.shields@shieldsoncology.com).

Published Online: May 30, 2013. doi:10.1001/jamaophthalmol.2013.67

Author Contributions: Dr C. L. Shields had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Conflict of Interest Disclosures: None reported.

Funding/Support: This work was supported by the Eye Tumor Research Foundation, Philadelphia, Pennsylvania (Drs C. L. Shields and J. A. Shields).

Honavar  SG, Shields  CL, Demirci  H, Shields  JA.  Sclerochoroidal calcification: clinical manifestations and systemic associations. Arch Ophthalmol. 2001;119(6):833-840.
PubMed   |  Link to Article
Shields  JA, Shields  CL.  CME review: sclerochoroidal calcification: the 2001 Harold Gifford Lecture. Retina. 2002;22(3):251-261.
PubMed   |  Link to Article
Schachat  AP, Robertson  DM, Mieler  WF,  et al.  Sclerochoroidal calcification. Arch Ophthalmol. 1992;110(2):196-199.
PubMed   |  Link to Article
Sivalingam  A, Shields  CL, Shields  JA,  et al.  Idiopathic sclerochoroidal calcification. Ophthalmology. 1991;98(5):720-724.
PubMed
Rao  RC, Choudhry  N, Gragoudas  ES.  Enhanced depth imaging spectral-domain optical coherence tomography findings in sclerochoroidal calcification. Retina. 2012;32(6):1226-1227.
PubMed   |  Link to Article
Yohannan  J, Channa  R, Dibernardo  CW,  et al.  Sclerochoroidal calcifications imaged using enhanced depth imaging optical coherence tomography. Ocul Immunol Inflamm. 2012;20(3):190-192.
PubMed   |  Link to Article
Daicker  B.  Tophus-like, conglomerated, crystalline calcification of the sclera. Ophthalmologica. 1996;210(4):223-228.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure.
Findings in an 86-Year-Old Woman With Sclerochoroidal Calcification

A, Geographic yellow subretinal lesion underlies the superotemporal retinal vascular arcade. B, B-scan ultrasonography demonstrates an acoustically solid mass with shadowing and thickness of 1.7 mm. C, The lesion is hyperautofluorescent. D, Infrared reflectance imaging shows bright clumps. E, Enhanced depth imaging optical coherence tomography demonstrates an elevated scleral mass with a “rocky” surface (arrows). There is thinning of the overlying choroid and outer nuclear layer as well as absence of the external limiting membrane and inner segment–outer segment junction. Slight irregular thickening of the retinal pigment epithelium is present.

Graphic Jump Location

Tables

Table Graphic Jump LocationTable 1.  Lesion Findings of Sclerochoroidal Calcification on Enhanced Depth Imaging Optical Coherence Tomography in 9 Patients With 13 Lesions
Table Graphic Jump LocationTable 2.  Choroidal and Retinal Findings of Sclerochoroidal Calcification on Enhanced Depth Imaging Optical Coherence Tomography in 9 Patients With 13 Lesions

References

Honavar  SG, Shields  CL, Demirci  H, Shields  JA.  Sclerochoroidal calcification: clinical manifestations and systemic associations. Arch Ophthalmol. 2001;119(6):833-840.
PubMed   |  Link to Article
Shields  JA, Shields  CL.  CME review: sclerochoroidal calcification: the 2001 Harold Gifford Lecture. Retina. 2002;22(3):251-261.
PubMed   |  Link to Article
Schachat  AP, Robertson  DM, Mieler  WF,  et al.  Sclerochoroidal calcification. Arch Ophthalmol. 1992;110(2):196-199.
PubMed   |  Link to Article
Sivalingam  A, Shields  CL, Shields  JA,  et al.  Idiopathic sclerochoroidal calcification. Ophthalmology. 1991;98(5):720-724.
PubMed
Rao  RC, Choudhry  N, Gragoudas  ES.  Enhanced depth imaging spectral-domain optical coherence tomography findings in sclerochoroidal calcification. Retina. 2012;32(6):1226-1227.
PubMed   |  Link to Article
Yohannan  J, Channa  R, Dibernardo  CW,  et al.  Sclerochoroidal calcifications imaged using enhanced depth imaging optical coherence tomography. Ocul Immunol Inflamm. 2012;20(3):190-192.
PubMed   |  Link to Article
Daicker  B.  Tophus-like, conglomerated, crystalline calcification of the sclera. Ophthalmologica. 1996;210(4):223-228.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com

The Rational Clinical Examination
Clinical Scenarios

The Rational Clinical Examination
Among Patients With Headaches, Who Should Have Neuroimaging?